Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL)
Clinical trial NCT04731727 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04731727
- Sponsor
- Kent Wellish MD
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2026-12-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.